Table 1.
Characteristics of HIV+ Older Adults (HOA) and Control Study Subjects
| Variable | Control (32) | HOA (54) | p-value |
|---|---|---|---|
| Age in years – Mean (S.D.) | 58.1 (6.5) | 56.7 (6.0) | 0.32 |
| BMI in kg/m2 – Mean (S.D.) | 27.9 (4.6) | 28.7 (5.3) | 0.45 |
| Gender (n% Male) | 20 (62.5%) | 41 (75.9%) | 0.19 |
| Race (n% White) | 25 (78.1%) | 31 (60.8%) | 0.20 |
| Ethnicity (n% Hispanic) | 3 (9.4%) | 3 (5.6%) | 0.50 |
| Hypertension (n% Yes) | 6 (18.7%) | 35 (64.8%) | <.01 |
| Diabetes (n% Yes) | 3 (9.4%) | 13 (24.1%) | 0.09 |
| Hyperlipidemia (n% Yes) | 2 (6.2%) | 27 (50.0%) | <.01 |
| Duration of HIV in years – Mean (S.D.) | - | 16.6 (6.2) | - |
| CD4 Count – Mean (S.D.) | - | 603.5 (270.6) | - |
| CD4 Nadir – Mean (S.D.) | - | 222.9 (175.7) | - |
| Viral Load (<50) copies – (n% Yes) | - | 41 (75.9%) | - |
| Current PI Use – (n% Yes) | - | 27 (50.0%) | - |
| Current N(t)RTI Use – (n% Yes) | - | 45 (83.3%) | - |
PI, Protease Inhibitors; N(t)RTI, Nucleoside/Nucleotide Reverse Transcriptase Inhibitors.